# Solara Active Pharma Sciences Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264

> Inspection records and compliance data for Solara Active Pharma Sciences Limited in Tamil Nadu, None. Access full analysis and detailed observations.

---

## Details

- Name: Solara Active Pharma Sciences Limited
- FEI Number: 3003585876
- City: Tamil Nadu
- State: None
- Country Name: India
- Address Line 1: A - 1/B Sipcot Industrial Complex
- Address Line 2: Kudikkadu
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1217304 - Solara Active Pharma Sciences Limited - 2023-08-04](https://www.globalkeysolutions.net/records/fda_inspections/solara-active-pharma-sciences-limited/294fb3d3-0209-47d3-82c5-7a7f63121e5a) — classification: No Action Indicated (NAI), source: FDA, date: August 4, 2023
- [483 - Solara Active Pharma Sciences Limited - 2020-03-07](https://www.globalkeysolutions.net/records/483/solara-active-pharma-sciences-limited/7d70b556-391f-40c4-9950-7b1d3edd1782) — source: FDA, date: March 7, 2020
- [483 - Solara Active Pharma Sciences Limited - 2020-03-07](https://www.globalkeysolutions.net/records/483/solara-active-pharma-sciences-limited/bfad62bb-d490-4053-9c63-d2a455c186ac) — source: FDA, date: March 7, 2020
- [FDA Inspection 1123376 - Solara Active Pharma Sciences Limited - 2020-03-07](https://www.globalkeysolutions.net/records/fda_inspections/solara-active-pharma-sciences-limited/b06c155c-f9f4-4d15-9b1c-575f05bc112a) — classification: Official Action Indicated (OAI), source: FDA, date: March 7, 2020
- [FDA Inspection 1012921 - Solara Active Pharma Sciences Limited - 2017-04-21](https://www.globalkeysolutions.net/records/fda_inspections/solara-active-pharma-sciences-limited/ade0ea5b-47b0-4547-b923-b16b4dc09046) — classification: No Action Indicated (NAI), source: FDA, date: April 21, 2017
- [EIR - Solara Active Pharma Sciences Limited - 2017-04-17](https://www.globalkeysolutions.net/records/eir/solara-active-pharma-sciences-limited/b52dee6b-7a2a-4bd6-be54-cb3191b49960) — source: FDA, date: April 17, 2017
- [FDA Inspection 888196 - Solara Active Pharma Sciences Limited - 2014-06-13](https://www.globalkeysolutions.net/records/fda_inspections/solara-active-pharma-sciences-limited/23ba0e2e-f2f9-4249-a5dd-cf49ce267266) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 13, 2014
- [FDA Inspection 719450 - Solara Active Pharma Sciences Limited - 2011-04-08](https://www.globalkeysolutions.net/records/fda_inspections/solara-active-pharma-sciences-limited/2df53902-a0e4-4271-8191-abb08e413d4e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 8, 2011
- [FDA Inspection 704735 - Solara Active Pharma Sciences Limited - 2010-11-16](https://www.globalkeysolutions.net/records/fda_inspections/solara-active-pharma-sciences-limited/6455395f-3d38-4e62-8676-2023005caf58) — classification: No Action Indicated (NAI), source: FDA, date: November 16, 2010

## Related Companies

- [Lonza Guangzhou Pharmaceutical Ltd.](https://www.globalkeysolutions.net/companies/lonza-guangzhou-pharmaceutical-ltd/eeb8d307-3663-4559-88cd-4e0696c0b556)
- [Apitoria Pharma Private Limited](https://www.globalkeysolutions.net/companies/apitoria-pharma-private-limited/c56154eb-1a77-4f64-9db0-4ae380d6b65e)
- [Bachem Americas, Inc.](https://www.globalkeysolutions.net/companies/bachem-americas-inc/f0157d2d-6b0c-4b13-afd4-551c2ab94aad)
- [Takeda Manufacturing Singapore Pte. Ltd.](https://www.globalkeysolutions.net/companies/takeda-manufacturing-singapore-pte-ltd/4ae048ca-a89e-47c7-b5a2-60d372157742)
- [Novacyl Roussillon](https://www.globalkeysolutions.net/companies/novacyl-roussillon/5a1bc6b5-5b17-4058-9698-82735b553d87)
- [Chinese Peptide Company](https://www.globalkeysolutions.net/companies/chinese-peptide-company/ba8c6a32-f679-405b-bb0a-e82713b7cb62)
- [Protein Sciences  Corporation](https://www.globalkeysolutions.net/companies/protein-sciences-corporation/5a8e39ec-a92e-42d6-a577-365d1d089624)
- [UBE Corporation](https://www.globalkeysolutions.net/companies/ube-corporation/76ca3dd5-0b44-4d3d-af9f-062d88ca7b3a)
- [Shilpa Pharma Lifesciences Limited](https://www.globalkeysolutions.net/companies/shilpa-pharma-lifesciences-limited/1267ea14-8591-45ec-9e82-4153a35a7028)
- [Cytovance Biologics Inc.](https://www.globalkeysolutions.net/companies/cytovance-biologics-inc/a03c370a-5e60-4617-95b1-521a1d305ac2)

## Related Officers

- [Branch Chief, Foreign Pharmaceutical Quality Inspection at FDA](https://www.globalkeysolutions.net/people/kevin-a-gonzalez/3f0a5230-3804-4df2-9a5e-3ea805ba9b79)
- [issuing_officer](https://www.globalkeysolutions.net/people/jeneen-a-huff-robersone/425ab23a-ab3f-4551-8c8a-fd0014184a99)
- [Miguel A. Martinez](https://www.globalkeysolutions.net/people/miguel-a-martinez/62e722b2-30bd-4671-9db9-8f089093e5a5)
- [Pharmaceuticals ](https://www.globalkeysolutions.net/people/zedong-dong/8ef8185c-523a-4b16-ab37-863746d71787)